Get a fresh start.
Add this topic to your myFT Digest for news straight to your inbox
Litigation will be long and tortuous, with billions of dollars at stake
America’s opioid epidemic — a tale of greed, individual suffering and official incompetence — will blight the country for years to come
Big businesses have benefited from building complex structures — can data restore power to the public?
A pharmaceuticals dynasty is under siege for its role in America’s addiction crisis
Accused of exaggerating the benefits of OxyContin, the company’s owners had a bigger share than realised
Purdue owners set up Rhodes Pharma after criminal charges in 2007
An investigation into the unfolding scandal of a company accused of fuelling America’s opioid crisis
Judge-led therapy programmes offer a rare glimmer of hope
Fixing the US opioid epidemic
The legal backlash against drugmakers echoes the fight against Big Tobacco
No other chronic disease is so costly and yet attracts so little early-stage research funding
UK pharma company removed work history at Purdue from Lewent’s biography
As overdose numbers soar, many experts are recommending medication over abstinence
Amount prescribed dropped 12% last year as moves to curb addiction crisis bore fruit
Australian island state grows almost half world’s supply of raw material in painkillers
President says US must get tough on ‘big pushers’ of drugs
Attorney-general says drug companies could face criminal penalties if they break the law
Drug overdose deaths in 2016 rose 21% from the previous year
Rules will help to reduce public’s exposure to addictive drugs, says US commissioner
The US can control abuse of the drug, if it will spend the money required
Report estimates public health emergency’s economic toll at almost 3% of GDP in 2015
Facebook founder homes in on opioids and technology to explain political polarisation
Drugmaker cleared by US regulatory panel to take on opioid emergency
Move criticised for failing to commit new federal funds to addiction crisis
